The structure of human aldose reductase bound to the inhibitor IDD384

被引:34
作者
Calderone, V
Chevrier, B
Van Zandt, M
Lamour, V
Howard, E
Poterszman, A
Barth, P
Mitschler, A
Lu, JH
Dvornik, DM
Klebe, G
Kraemer, O
Moorman, AR
Moras, D
Podjarny, A
机构
[1] IGBMC, CNRS, INSERM, ULP,UPR Biol Struct 9004, F-67404 Illkirch Graffenstaden, France
[2] Inst Diabet Discovery, Branford, CT USA
[3] Univ Strasbourg, Inst Chim, Lab Chim Organ Biol, F-67008 Strasbourg, France
[4] Univ Marburg, IPC, D-35032 Marburg, Germany
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2000年 / 56卷
关键词
D O I
10.1107/S0907444900002341
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The crystallographic structure of the complex between human aldose reductase (AR2) and one of its inhibitors, IDD384, has been solved at 1.7 Angstrom resolution from crystals obtained at pH 5.0. This structure shows that the binding of the inhibitor's hydrophilic head to the catalytic residues Tyr48 and His110 differs from that found previously with porcine AR2. The difference is attributed to a change in the protonation state of the inhibitor (pK(a) = 4.52) when soaked with crystals of human (at pH 5.0) or pig lens AR2 (at pH 6.2). This work demonstrates how strongly the detailed binding of the inhibitor's polar head depends on its protonation state.
引用
收藏
页码:536 / 540
页数:5
相关论文
共 18 条
[1]   TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN THE REDUCTION REACTION OF HUMAN ALDOSE REDUCTASE - ENZYME-KINETICS AND CRYSTAL-STRUCTURE OF THE Y48H MUTANT ENZYME [J].
BOHREN, KM ;
GRIMSHAW, CE ;
LAI, CJ ;
HARRISON, DH ;
RINGE, D ;
PETSKO, GA ;
GABBAY, KH .
BIOCHEMISTRY, 1994, 33 (08) :2021-2032
[2]  
Brunger A., 1992, XPLOR SYSTEM CRYSTAL
[3]   KINETIC CHARACTERISTICS OF ZENECA ZD5522, A POTENT INHIBITOR OF HUMAN AND BOVINE LENS ALDOSE REDUCTASE [J].
COOK, PN ;
WARD, WHJ ;
PETRASH, JM ;
MIRRLEES, DJ ;
SENNITT, CM ;
CAREY, F ;
PRESTON, J ;
BRITTAIN, DR ;
TUFFIN, DP ;
HOWE, R .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (08) :1043-1049
[4]   INHIBITORY ACTIVITY AND MECHANISM OF INHIBITION OF THE N-[[(4-BENZOYLAMINO)PHENYL]SULFONYL]AMINO ACID ALDOSE REDUCTASE INHIBITORS [J].
DERUITER, J ;
MAYFIELD, CA .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) :2219-2226
[5]  
DVORNIK D, 1988, POLYOL PATHWAY ITS R, P61
[6]  
DVORNIK D, 1994, DESIGN ENZYME INHIBI, V2, P710
[7]  
El-Kabbani O, 1999, MOL VIS, V5, pU1
[8]  
GNONEN A, 1995, CLIN SCI DIABETES, P313
[9]   IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS [J].
JONES, TA ;
ZOU, JY ;
COWAN, SW ;
KJELDGAARD, M .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :110-119
[10]   Production of crystals of human aldose reductase with very high resolution diffraction [J].
Lamour, V ;
Barth, P ;
Rogniaux, H ;
Poterszman, A ;
Howard, E ;
Mitschler, A ;
Van Dorsselaer, A ;
Podjarny, A ;
Motas, D .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 :721-723